The move to cease operations comes after a tumultuous year for Martin University. The east-side college is Indiana’s only predominantly Black institution.
Construction is set to begin early next year on a $560 million project to send millions of gallons of water each day to Lebanon to meet the demands of the state’s 9,000-acre LEAP Research and Innovation District.
We were excited last week when state officials announced a public–private investment of nearly $75 million to accelerate literacy, expand high-quality summer learning, strengthen STEM programs, modernize and expand career advising, and maintain digital learning tools for Hoosier students.
In an open letter on the team’s website, CEO Kevin Warren said the Bears will expand its search for a stadium site to a larger region that will include Indiana.
Earlier this year, LDI announced that former Indiana Gov. Mitch Daniels had joined its team as the company’s first executive partner, with the goal of focusing on investments in Indiana-based companies.
For several years, the common refrain among some state lawmakers has been that they had no desire to tackle the issue until the federal government reclassified the drug. That argument will be removed if the president’s order receives federal regulatory approval as directed.
Eli Lilly and Co.’s career website this month listed 254 job openings in Indianapolis and another 90 in Lebanon, accounting for more than three-quarters of the 445 open positions the pharmaceutical giant listed across the United States.
December serves as a deadline of sorts for donors, with the National Philanthropic Trust estimating that nearly one-third of annual giving happens in the final month.
Novo Nordisk’s Wegovy pills are expected to be available within weeks, while Indianapolis-based Eli Lilly and Co. waits for approval for its daily GLP-1 pill, orforglipron.
The integration of AI adds a new layer of legal precautions for corporate counsel to navigate to ensure that both their companies and employees comply with company policy and ethical standards.
As of Nov. 13, Eli Lilly and Co.’s market capitalization was $967 billion and flirting with a rare $1 trillion. Its stock price in November surpassed $1,000 per share, up more than 25% for the year.
